Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines

Margaret R. O'Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal Attar, Uma Borate, Steven E. Coutre, Lloyd E. Damon, Jeffrey Lancet, Lori J Maness-Harris, Guido Marcucci, Michael G. Martin, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. StoneStephen A. Strickland, Eunice S. Wang, Kristina M. Gregory, Maoko Naganuma

Research output: Contribution to journalReview article

95 Scopus citations


These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

Original languageEnglish (US)
Pages (from-to)1047-1055
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number9
StatePublished - Sep 1 2013


ASJC Scopus subject areas

  • Oncology

Cite this

O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Attar, E., Borate, U., Coutre, S. E., Damon, L. E., Lancet, J., Maness-Harris, L. J., Marcucci, G., Martin, M. G., Millenson, M. M., Moore, J. O., Ravandi, F., Shami, P. J., Smith, B. D., ... Naganuma, M. (2013). Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 11(9), 1047-1055.